New and Generic Drug Approvals:
*CANCIDAs (caspofungin acetate) I.V. Injection, Merck Research Laboratories, Patient Population Altered *Divalproex Sodium Delayed-Release Tablets, Dr. Reddy's Laboratories, Ltd., Approval *Divalproex Sodium Delayed-Release Tablets, Genpharm, ULC, Approval *Divalproex Sodium Delayed-Release Tablets, Lupin Pharmaceuticals, Inc., Approval *Divalproex Sodium Delayed-Release Tablets, Nu-Pharm, Inc., Approval *Divalproex Sodium Delayed-Release Tablets, Sandoz, Inc., Approval *Divalproex Sodium Delayed-Release Tablets, Sun Pharmaceutical Industries, Ltd., Approval *Divalproex Sodium Delayed-Release Tablets, Teva Pharmaceuticals USA, Approval *Divalproex Sodium Delayed-Release Tablets, Upsher-Smith Laboratories, Inc., Approval *Fortamet (metformin hydrochloride) Extended-Release Tablets, Andrx Pharmaceuticals, LLC, Labeling Revision *Mycophenolate Mofetil Capsules, Roxane Laboratories, Inc., Approval *Mycophenolate Mofetil Tablets, Roxane Laboratories, Inc., Approval *PRIMAQUINE (primaquine phosphate) Tablets, Sanofi-Aventis US, LLC, Labeling Revision *STAVZOR (valproic acid) Delayed-Release Capsules, Banner Pharmacaps, Inc., Approval *Sumatriptan Succinate Injection, Teva Parenteral Medicines, TENTATIVE Approvall 


Zynchros Pharmacy Services